Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

House Medicare Rx Bill Calls For GAO Study Of Part B Payments Prior To Cuts

Executive Summary

The General Accounting Office would conduct a study of Medicare payment levels for currently covered drugs and biologics under an amendment to Medicare prescription drug legislation that was approved by the House Ways & Means Committee June 21.

You may also be interested in...



HCFA Revised AWP List For Medicare Rx Reimbursement Suspended

The Health Care Financing Administration is suspending implementation of a new average wholesale price list for drugs covered by Medicare for one year.

HCFA Revised AWP List For Medicare Rx Reimbursement Suspended

The Health Care Financing Administration is suspending implementation of a new average wholesale price list for drugs covered by Medicare for one year.

Merck-Medco Assures Congress It is Ready To Insure Drug Coverage

Merck-Medco is ready to make the move from pharmacy benefit manager to drug insurer if Congress takes the private insurance approach to Medicare drug benefits.

Related Content

UsernamePublicRestriction

Register

ID036688

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel